Abiopharma

🔍 Van de Put Dirk (Director)

Company: Mondelez International, Inc. (MDLZ)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Acquired 133,580 shares of Class A Common Stock at $42.11 per share (Direct)
  Date: 2026-08-19 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,460,068.00 | transaction_form_type: 4
• Sold 133,580 shares of Class A Common Stock at $64.08 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 1,326,488.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 133,580 shares of Stock Options (right to buy) at $42.11 per share (Derivative)
  Date: 2026-08-19 | Code: M | Expires: 2027-11-20 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 15, 2026.
• F2: The price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.00 to $64.16, inclusive. The reporting person undertakes to provide to Mondelez International, Inc., any security holder of Mondelez International, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4.
• F3: This Form 4 is being filed to report the exercise of stock options that became 100% exercisable on February 16, 2020, and expire on November 20, 2027.